Results for tag: "Bursitis Drug"

The Bursitis Drug market is a segment of the Musculoskeletal Disorders Drugs market. Bursitis is a condition that causes inflammation of the bursae, which are small sacs of fluid that cushion the joints. Treatment for bursitis typically involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. In some cases, surgery may be necessary. The Musculoskeletal Disorders Drugs market is a large and growing market, driven by an aging population and increasing prevalence of musculoskeletal disorders. The market is expected to continue to grow in the coming years, driven by the increasing prevalence of musculoskeletal disorders and the development of new treatments. Some companies in the Bursitis Drug market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more